Wednesday, September 7, 2016

BRIEF-Epizyme's Tazemetostat study surpassed pre-specified futility hurdle - committee

* Independent data monitoring committee confirmed that study

cohort related to tazemetostat has surpassed its pre-specified

futility hurdle

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)